Encompass Health Corporation $EHC Stock: Fort Washington Investment Advisors Inc. OH Raises Position

Fort Washington Investment Advisors Inc. OH grew its stake in Encompass Health Corporation (NYSE:EHC) by 19.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 281,075 shares of the company’s stock after buying an additional 46,512 shares during the period. Fort Washington Investment Advisors Inc. OH’s holdings in Encompass Health were worth $34,148,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Transamerica Financial Advisors LLC acquired a new stake in Encompass Health during the 2nd quarter worth $29,000. Toth Financial Advisory Corp purchased a new stake in Encompass Health in the third quarter valued at $38,000. Persistent Asset Partners Ltd acquired a new position in Encompass Health in the second quarter valued at $36,000. Keating Financial Advisory Services Inc. acquired a new position in Encompass Health in the second quarter valued at $39,000. Finally, Assetmark Inc. grew its holdings in shares of Encompass Health by 89.6% during the first quarter. Assetmark Inc. now owns 455 shares of the company’s stock worth $44,000 after purchasing an additional 215 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

EHC has been the topic of a number of research analyst reports. Raymond James Financial set a $150.00 target price on Encompass Health in a research report on Monday, September 28th. UBS Group upped their target price on Encompass Health from $150.00 to $155.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Weiss Ratings raised Encompass Health from a “buy (b-)” rating to a “buy (b)” rating in a research report on Thursday, October 8th. Barclays raised their price target on Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Finally, TD Cowen lifted their price target on Encompass Health from $125.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, Encompass Health presently has a consensus rating of “Buy” and a consensus price target of $148.50.

Encompass Health Stock Performance

NYSE EHC opened at $126.36 on Thursday. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 52-week low of $92.77 and a 52-week high of $127.99. The business’s 50-day moving average price is $122.40 and its 200 day moving average price is $111.24. The firm has a market cap of $12.47 billion, a P/E ratio of 20.58, a P/E/G ratio of 2.52 and a beta of 0.74.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.48 by $0.07. The firm had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%. The firm’s revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.40 EPS. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, equities research analysts expect that Encompass Health Corporation will post 6.08 earnings per share for the current year.

Encompass Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be issued a $0.21 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This is an increase from Encompass Health’s previous quarterly dividend of $0.19. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio is presently 13.68%.

Insider Buying and Selling

In other news, EVP John Darby sold 8,906 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $125.95, for a total transaction of $1,121,710.70. Following the completion of the sale, the executive vice president owned 75,041 shares in the company, valued at $9,451,413.95. This represents a 10.61% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Mark Tarr sold 173,148 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $125.47, for a total value of $21,724,879.56. Following the sale, the chief executive officer owned 267,814 shares of the company’s stock, valued at $33,602,622.58. This trade represents a 39.27% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 186,912 shares of company stock worth $23,434,845. Corporate insiders own 1.80% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation (NYSE:EHC) is a healthcare services company focused on inpatient rehabilitation. Through its network of rehabilitation hospitals, the company provides intensive medical and therapeutic care to patients recovering from conditions such as strokes, brain and spinal cord injuries, hip fractures, amputations, neurological disorders, and other disabling illnesses or injuries.

Its rehabilitation hospitals offer coordinated care from physicians, nurses, therapists, and other healthcare professionals.